Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses

部分流量储备 医学 心脏病学 血运重建 冠状动脉血流储备 内科学 心肌梗塞 临床终点 冠状动脉疾病 临床试验 冠状动脉造影
作者
Nils P. Johnson,Hitoshi Matsuo,Masafumi Nakayama,Ashkan Eftekhari,Tsunekazu Kakuta,Nobuhiro Tanaka,Evald Høj Christiansen,Richard L. Kirkeeide,K. Lance Gould
出处
期刊:Jacc-cardiovascular Interventions [Elsevier BV]
卷期号:14 (17): 1904-1913 被引量:33
标识
DOI:10.1016/j.jcin.2021.07.041
摘要

OBJECTIVES The aim of this study was to assess clinical outcomes after combined pressure and flow assessment of coronary lesions.BACKGROUND Although fractional flow reserve (FFR) remains the invasive reference standard for revascularization, approximately 40% of stenoses have discordant coronary flow reserve (CFR).Optimal treatment for these disagreements remains unclear.METHODS A total of 455 subjects with 668 lesions were enrolled from 12 sites in 6 countries.Only lesions with reduced FFR and CFR underwent revascularization; all other combinations received initial medical therapy.RESULTS Fourteen percent of lesions had FFR #0.8 but CFR $2.0 while 23% of lesions had FFR >0.8 but CFR <2.0.During 2-year follow-up, the primary endpoint of composite all-cause death, myocardial infarction, and revascularization in lesions with FFR #0.8 but CFR $2.0 (10.8% event rate) compared with lesions with FFR >0.8 and CFR $2.0 (6.2% event rate) exceeded the prespecified þ10% noninferiority margin (P ¼ 0.090).Target vessel failure models using both continuous FFR and continuous CFR found that only higher FFR was associated with reduced target vessel failure (Cox P ¼ 0.007) after initial medical treatment.Central core laboratory review accepted 69.8% of all tracings with mean differences of <0.01 for FFR and <0.02 for CFR, indicating no material impact on clinical measurements or outcomes.CONCLUSIONS All-cause death, myocardial infarction, and revascularization after 2 years was not noninferior between lesions with FFR #0.8 but CFR $2.0 and lesions with FFR >0.8 and CFR $2.0.These results do not support using invasive CFR $2.0 to defer revascularization for lesions with reduced FFR if the patient would otherwise be a candidate on the basis of the entire clinical scenario and treatment preference.(
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
cdercder应助科研通管家采纳,获得10
刚刚
cdercder应助科研通管家采纳,获得10
刚刚
充电宝应助科研通管家采纳,获得10
刚刚
xxl完成签到,获得积分10
刚刚
强健的糖豆完成签到,获得积分10
1秒前
梓凝完成签到 ,获得积分10
1秒前
婷123完成签到 ,获得积分10
1秒前
南北完成签到,获得积分10
1秒前
壮观的饼干完成签到,获得积分10
2秒前
黑森林完成签到,获得积分10
2秒前
科研通AI5应助百里如雪采纳,获得10
2秒前
简单的卿完成签到,获得积分10
2秒前
2秒前
冷酷的乐驹完成签到 ,获得积分10
2秒前
4秒前
妩媚的日记本完成签到,获得积分10
4秒前
ggg完成签到,获得积分10
5秒前
千秋凌完成签到,获得积分10
5秒前
奇迹世界完成签到,获得积分10
5秒前
jzm发布了新的文献求助30
5秒前
5秒前
甜蜜鹭洋完成签到 ,获得积分10
5秒前
科目三应助星辰迷殇采纳,获得10
6秒前
6秒前
6秒前
乐观的眼睛完成签到,获得积分10
6秒前
邓晓霞完成签到,获得积分10
6秒前
7秒前
7秒前
lhy33966发布了新的文献求助10
7秒前
豌豆完成签到 ,获得积分10
7秒前
ABCDE完成签到,获得积分10
8秒前
菲菲完成签到,获得积分10
8秒前
木子草甜完成签到,获得积分10
8秒前
9秒前
fd163c发布了新的文献求助10
9秒前
Scarlett完成签到,获得积分10
9秒前
157281完成签到,获得积分10
9秒前
等待的绿旋完成签到,获得积分20
9秒前
大个应助秋天采纳,获得10
10秒前
高分求助中
ISCN 2024 - An International System for Human Cytogenomic Nomenclature (2024) 3000
Les Mantodea de Guyane Insecta, Polyneoptera 2500
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 (PDF!) 1000
Technologies supporting mass customization of apparel: A pilot project 450
Tip60 complex regulates eggshell formation and oviposition in the white-backed planthopper, providing effective targets for pest control 400
A Field Guide to the Amphibians and Reptiles of Madagascar - Frank Glaw and Miguel Vences - 3rd Edition 400
China Gadabouts: New Frontiers of Humanitarian Nursing, 1941–51 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3788571
求助须知:如何正确求助?哪些是违规求助? 3333821
关于积分的说明 10264588
捐赠科研通 3049861
什么是DOI,文献DOI怎么找? 1673719
邀请新用户注册赠送积分活动 802186
科研通“疑难数据库(出版商)”最低求助积分说明 760549